Biotest Aktiengesellschaft (ETR:BIO3)
Germany
· Delayed Price · Currency is EUR 30.20
+0.20 (0.67%)
Apr 17, 2025, 5:36 PM CET
ETR:BIO3 Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 26.4 | 127 | -31.7 | -63.4 | -31.4 | Upgrade
|
| Depreciation & Amortization | 40.5 | 35.8 | 35.8 | 31.1 | 29.7 | Upgrade
|
| Other Amortization | 0.1 | 0.1 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.1 | -23.1 | - | - | 0.2 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -4.7 | Upgrade
|
| Loss (Gain) on Equity Investments | 14 | -2.4 | 0.7 | -1.3 | 0.5 | Upgrade
|
| Provision & Write-off of Bad Debts | -7.9 | - | - | - | - | Upgrade
|
| Other Operating Activities | -11.9 | 28.4 | -0.1 | 45.9 | 21.8 | Upgrade
|
| Change in Inventory | -11.4 | -213.4 | -76.1 | 23.8 | -29.9 | Upgrade
|
| Change in Accounts Payable | 7 | 45.3 | 24.8 | - | -4.9 | Upgrade
|
| Change in Other Net Operating Assets | 4.2 | -0.4 | 6.1 | -2.3 | 2 | Upgrade
|
| Operating Cash Flow | 60.9 | -2.7 | -40.5 | 33.8 | -16.7 | Upgrade
|
| Capital Expenditures | -28.7 | -33.4 | -29.3 | -18.2 | -27 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.2 | 1 | - | 0.3 | 0.1 | Upgrade
|
| Divestitures | - | 35 | - | - | - | Upgrade
|
| Investment in Securities | 1.7 | -2.4 | -7.8 | -5.5 | 11.5 | Upgrade
|
| Other Investing Activities | 1.1 | 1.1 | 0.1 | - | 0.8 | Upgrade
|
| Investing Cash Flow | -25.7 | 1.3 | -37 | -23.4 | -14.6 | Upgrade
|
| Long-Term Debt Issued | 197.4 | 10.1 | 100 | 25.1 | 50 | Upgrade
|
| Long-Term Debt Repaid | -230.2 | -19 | -5.8 | -5.3 | -7.3 | Upgrade
|
| Net Debt Issued (Repaid) | -32.8 | -8.9 | 94.2 | 19.8 | 42.7 | Upgrade
|
| Common Dividends Paid | -1.6 | - | -0.8 | -0.8 | -0.8 | Upgrade
|
| Other Financing Activities | -1 | 2.1 | -3.8 | 3.6 | 0.1 | Upgrade
|
| Financing Cash Flow | -35.4 | -6.8 | 89.6 | 22.6 | 42 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.1 | 0.1 | - | - | -0.2 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | -0.4 | 0.1 | 0.1 | - | Upgrade
|
| Net Cash Flow | -0.3 | -8.5 | 12.2 | 33.1 | 10.5 | Upgrade
|
| Free Cash Flow | 32.2 | -36.1 | -69.8 | 15.6 | -43.7 | Upgrade
|
| Free Cash Flow Margin | 4.43% | -5.27% | -13.53% | 3.03% | -9.03% | Upgrade
|
| Free Cash Flow Per Share | 0.81 | -0.91 | -1.76 | 0.39 | -1.10 | Upgrade
|
| Cash Interest Paid | 20.3 | 24.2 | 13.1 | 12.8 | 6.6 | Upgrade
|
| Cash Income Tax Paid | 8.7 | 11.7 | 2 | 0.9 | 2 | Upgrade
|
| Levered Free Cash Flow | -5.79 | -68.74 | -71.69 | 28.64 | -61.04 | Upgrade
|
| Unlevered Free Cash Flow | 13.15 | -45.86 | -60.13 | 36.39 | -52.85 | Upgrade
|
| Change in Net Working Capital | 53 | 121.3 | 54 | -55.3 | 50.8 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.